November 2, 2026 · Neurourology and urodynamics · DOI: 10.1002/nau.70528

Deflux and Botulinum Toxin Type A as Combined Therapeutic Approach in Pediatric Vesicoureteral Reflux and Concurrent Non-Neurogenic Dysfunctional Voiding: Insights From a Prospective Single-Arm Study.

Listen to this summary

This prospective single-arm study asked whether combining endoscopic Deflux injection for vesicoureteral reflux with pelvic floor and periurethral botulinum toxin A injection could improve uroflowmetry patterns and quality of life in girls with concurrent non-neurogenic dysfunctional voiding. In 30 patients, voiding patterns normalized to near bell-shaped in 76.7% at 6 months and 90% at 1 year, with 87% of refluxing renal units showing complete reflux resolution at 6 months. The PinQ quality-of-life score also fell significantly, from 20.83 to 11.26 at 1 year, suggesting the combined approach benefits both voiding function and symptoms, though the lack of a control arm limits causal conclusions.

Negar Mohammadi Ganjaroudi, Negin Jarrah, Parmida Sadat Pezeshki, Shervin Tavakoli, Abdol-Mohammad Kajbafzadeh

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play